RESUMO
Human platelet antigen (HPA) polymorphisms are considered to be a risk factor for cardiac and vascular diseases, but the role of HPA in chronic Chagas disease cardiomyopathy (CCC) is not available. Therefore, the aim of this study was to investigate the association of HPA polymorphisms, HPA-1, HPA-2, HPA-3, HPA-5 and HPA-15, in the severity of left ventricular systolic dysfunction (LVSD) in CCC patients. For this, 229 CCC patients were separated into three groups: without LVSD, mild/moderate LVSD and severe LVSD. PCR-SSP was performed for HPA genotyping and the risk was assessed using SNPStats software. HPA-1 allele and genotype frequencies were lower in mild/moderate LVSD patients compared to other groups, without statistical significance. After stratified analyzes, the HPA-3a/3b genotype frequency was lower in women with severe LVSD compared to those without LVSD (OR:0.29; 95% CI: 0.10-0.84). In conclusion, HPA-3 variant could be a protection factor for CCC in the female patients.
Assuntos
Antígenos de Plaquetas Humanas/genética , Cardiomiopatia Chagásica/genética , Polimorfismo Genético/genética , Cardiomiopatia Chagásica/patologia , Doença Crônica , Feminino , Humanos , Masculino , Fatores de RiscoRESUMO
The coronavirus disease 2019 (COVID-19) pandemic has turned pregnant women's healthcare into a worldwide public health challenge. Although initial data did not demonstrate pregnancy as a more susceptible period to severe outcomes of acute severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection, there are an increasing number of reports showing that not only pregnant women might be at significantly higher risk than non-pregnant women by COVID-19 but also the fetus. These findings may be related to adaptive changes that occur during pregnancy, such as the reduction in the residual respiratory capacity, the decrease in viral immune responses, and the increased risk for thromboembolic events. Additionally, despite the SARS-CoV-2 vertical transmission evidence being uncommon, maternal illness severity might reflect serious perinatal and neonatal outcomes. Thus, protecting the maternal-fetal dyad against COVID-19 is critical. Even though pregnant women initially were excluded from vaccine trials, several studies have provided safety and efficacy of the overall vaccine COVID-19 platforms. Vaccination during pregnancy becomes a priority and can generate benefits for both the mother and newborn: maternal neutralizing antibodies are transmitted through the placenta and breastfeeding. Moreover, regarding passive immunization, human milk contains other bioactive molecules and cells able to modulate the newborn's immune response, which can be amplified after the vaccine. Nonetheless, many issues remain to be elucidated, considering the magnitude of the protective immunity transferred, the duration of the induced immunity, and the optimal interval for pregnant immunization. In this review, we assessed these unmet topics supported by literature evidence regarding the vaccine's immunogenicity, pregnancy immune heterogeneity, and the unique human milk antiviral features.
Assuntos
COVID-19 , Complicações Infecciosas na Gravidez , Vacinas , Aleitamento Materno , COVID-19/prevenção & controle , Feminino , Humanos , Recém-Nascido , Pandemias/prevenção & controle , Placenta , Gravidez , Complicações Infecciosas na Gravidez/prevenção & controle , SARS-CoV-2RESUMO
The study aimed to measure serum fatty acids (FAs) composition in HIV carrier patients and compare it with non-HIV carrier patients. The FAs composition was measured by gas chromatography as follows: four saturated FAs myristic acid (14:0), palmitic acid (16:0), stearic acid (18:0), and docosanoic acid (22:0); four monounsaturated FAs 7-hexadecenoic acid (16:1 n-9), palmitoleic acid (16:1 n-7), oleic acid (18:1 n-9), and vaccenic acid (18:1 n-7); and three polyunsaturated FAs linoleic acid (18:2 n-6), dihomo-γ-linolenic acid (20:3 n-6), and docosahexaenoic acid (DHA, 22:6 n-3). We reported herein lower (P < .05) DHA concentration (by 40%) in the serum of HIV carrier patients than in non-HIV carrier patients. This FA has a pivotal role as a precursor of anti-inflammatory molecules with beneficial effects on metabolism, cardiovascular system, and immunological system. Even though most clinical studies reported beneficial effects of DHA supplementation in HIV carrier patients, this issue remains under debate. Further investigations then require to fully clarify the role of DHA in preventing or alleviating the comorbidities associated with HIV infection.
Assuntos
Ácidos Docosa-Hexaenoicos , Infecções por HIV , Cromatografia Gasosa , Ácidos Graxos , Ácidos Graxos Insaturados , Infecções por HIV/tratamento farmacológico , Humanos , Ácido OleicoRESUMO
Despite intense efforts, the number of new cases of leprosy has remained significantly high over the past 20 years. Host genetic background is strongly linked to the pathogenesis of this disease, which is caused by Mycobacterium leprae (M. leprae), and there is a consensus that the most significant genetic association with leprosy is attributed to the major histocompatibility complex (MHC). Here, we investigated the association of human leukocyte antigen (HLA) class I and II genes with leprosy in a Brazilian population encompassing 826 individuals from a hyperendemic area of Brazil; HLA typing of class I (-A, -B, -C) and class II (-DRB1, -DQA1, -DQB1, -DPA1, and -DPB1) loci was conducted. Initially, the associations were tested using the chi-square test, with p-values adjusted using the false discovery rate (FDR) method. Next, statistically significant signals of the associations were submitted to logistic regression analyses to adjust for sex and molecular ancestry data. The results showed that HLA-C*08, -DPB1*04, and -DPB1*18 were associated with protective effects, while HLA-C*12 and -DPB1*105 were associated with susceptibility to leprosy. Thus, our findings reveal new associations between leprosy and the HLA-DPB1 locus and confirm previous associations between the HLA-C locus and leprosy.
Assuntos
Predisposição Genética para Doença , Antígenos HLA-C/genética , Cadeias beta de HLA-DP/genética , Hanseníase/genética , Adolescente , Adulto , Idoso , Alelos , Brasil/epidemiologia , Estudos de Casos e Controles , Doenças Endêmicas , Feminino , Loci Gênicos , Antígenos HLA-C/imunologia , Cadeias beta de HLA-DP/imunologia , Humanos , Hanseníase/epidemiologia , Hanseníase/imunologia , Hanseníase/microbiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae/imunologia , Adulto JovemRESUMO
Sixty hundred and forty-one Brazilian individuals from the north and northwestern state of Paraná, southern Brazil, were selected for the study. The HLA-A, -B, -DRB1, -DQA1, and -DQB1 genotyping were performed using rSSO and Micro SSP analysis. These genotype data are available in the Allele Frequencies Net Database under the population name "Brazil Paraná Caucasian" number "AFND3618".
Assuntos
Genótipo , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Cadeias alfa de HLA-DQ/genética , Cadeias beta de HLA-DQ/genética , Cadeias HLA-DRB1/genética , Brasil , Feminino , Técnicas de Genotipagem , Humanos , MasculinoRESUMO
Polycystic ovary syndrome (PCOS) affects the endocrine system and is associated with low-grade inflammation. Natural killer (NK) cells are involved in the defense of the female reproductive tract, folliculogenesis, ovulation and the menstrual cycle. The killer-cell immunoglobulin-like receptors (KIR) on the surface of NK cells modulate the activation and function of these cells after interacting with human leukocyte antigen (HLA) class I ligands. The objective of this study was to evaluate the possible association of the KIR and their HLA ligands with polycystic ovary syndrome. METHODS: Ninety-three patients with PCOS according to the Rotterdam criteria and 104 healthy controls were included in this study. The HLA class I and KIR genotypes were determined using a PCR-SSO technique, rSSO Luminex®. In order to assess whether the distribution of the HLA and KIR genotypes was in Hardy-Weinberg equilibrium, Arlequin 3.1 software was used. The frequency distributions in the two study groups were compared using the chi-squared statistic with Yates´s correction using Open Epi software. RESULTS: The higher frequencies of KIR3DS1-Bw4 (41% vs. 19%, Pc = 0.002; OR = 2.90) and homozygotic KIR2DS4-del (54% vs. 26%, Pc = 0.0002; OR = 3.316) in patients compared with controls suggest they confer susceptibility to PCOS. A lower frequency of KIR2DS4-full was observed in patients (43% vs. 70%, Pc = 0.0004, OR = 0.320). CONCLUSION: KIR and its HLA ligands were associated with the development of PCOS in the studied population.
Assuntos
Predisposição Genética para Doença , Células Matadoras Naturais/imunologia , Síndrome do Ovário Policístico/genética , Receptores KIR3DS1/genética , Receptores KIR/genética , Adulto , Estudos de Casos e Controles , Epitopos/genética , Epitopos/imunologia , Feminino , Frequência do Gene , Técnicas de Genotipagem , Antígenos de Histocompatibilidade Classe I/imunologia , Antígenos de Histocompatibilidade Classe I/metabolismo , Homozigoto , Humanos , Células Matadoras Naturais/metabolismo , Síndrome do Ovário Policístico/imunologia , Receptores KIR/imunologia , Receptores KIR3DS1/imunologia , Adulto JovemRESUMO
Graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic stem cell transplantation (HSCT), and cytokines are recognized as important mediators of GVHD. Polymorphisms in the regulatory regions of several cytokine genes have been associated with a number of immune diseases as well as organ transplant complications. In this study we have investigated the role of tumor necrosis factor-alpha(-308), interleukin (IL)-6(-174), IL-10(-1082, -819, -592), Interferon-gamma(-874), and transforming growth factor-beta1(+869, +915) polymorphisms on HSCT outcome. Donor/recipient genotypes were analyzed by polymerase chain reaction with sequence specific primers (PCR-SSP). Although we have found a small number of low IL-6, a polymorphism at position -174 of the recipient and donor IL-6 gene was associated with the increased incidence of chronic GVHD. Therefore, this study emphasizes the probable potential role of genetic variability of donor and recipient in determining outcome after transplantation.
Assuntos
Citocinas/genética , Doença Enxerto-Hospedeiro/genética , Transplante de Células-Tronco Hematopoéticas , Polimorfismo Genético , Adolescente , Adulto , Brasil , Criança , Pré-Escolar , Variação Genética , Doença Enxerto-Hospedeiro/imunologia , Doença Enxerto-Hospedeiro/mortalidade , Transplante de Células-Tronco Hematopoéticas/mortalidade , Células-Tronco Hematopoéticas , Humanos , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Transplante HomólogoRESUMO
El espinazo de tilapia (Oreochormis niloticus) es una parte del pescado con composición desconocida. Se obtuvo y analizó la harina de espinazo de tilapia. Los resultados hallados cada 100 gramos de producto fueron: humedad (14.2g), proteína (40.8g), lípidos totales (25.3g), cenizas (18.3g) y calorias (391Kcal). El contenido de minerales en 100g fue calcio (2715.9mg), hierro (1.3mg), y fósforo (1132.7mg). Un total de 22 ácidos grasos fueron encontrados en los lípidos totales de la harina de espinazo, siendo los mayoritarios por g de lípidos totales: 16:0 (208.5mg); 18:1n-9 (344.3mg) y 18:2n-6 (109.6mg). La concentración de ácido linolênico -LNA (18:3n-3); ácido eicosapentaenóico - EPA (20:5n-3), y ácido docosahexaenóico - DHA (22:6n-3) fueron (29.9mg), (3.3mg), y (12.9mg), respectivamente. El contenido de los saturados (SFA) fue 296.2mg, monoinsaturados (MUFA) 415.0mg y polinsaturados (PUFA) 175.6mg. La razón PUFA:MUFA:SFA fue 1:2, 4:1.7 y la razón ácidos grasos omega-6/ácidos grasos omega-3 fue 2.8. Esta última está de acuerdo con los valores recomendados. Los resultados mostraron bajas concentraciones de ácidos grasos omega 3 en la harina; sin embargo, por su aporte calórico, y por su contenido de calcio, hierro, fósforo y proteínas la harina del espinazo de tilapia puede resultar una alternativa interesante para la dieta humana.